News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Pezcoller Symposium Highlights 2025: Studying and Treating Cancer in the Digital Era – ESO
ESO/X
Aug 26, 2025, 16:55

Pezcoller Symposium Highlights 2025: Studying and Treating Cancer in the Digital Era – ESO

European School of Oncology (ESO) shared a post on X:

“Save the date!

Pezcoller Symposium Highlights 2025: Studying and Treating Cancer in the Digital Era
  • 4 September
  • 18:15 CEST

With Lunardi, Romanel, Cherchi, and Leonardi from The Department of Cellular, Computational and Integrative Biology at the University of Trento.

In collaboration with Pezcoller Foundation.”

Register.

Pezcoller Symposium Highlights 2025: Studying and Treating Cancer in the Digital Era - ESO

More posts featuring European School of Oncology.

cancer eso European School of Oncology OncoDaily Oncology Pezcoller Foundation Pezcoller Symposium Highlights 2025
Special Coverage
Voices
Aug 26, 2025, 16:55
Pezcoller Symposium Highlights 2025: Studying and Treating Cancer in the Digital Era - ESO
Blog Posts
Aug 26, 2025, 16:36
Michaela Boland: Seeking a Liver Donor with Support from URMC
Insight
Aug 26, 2025, 16:19
David J. Skorton: Supporting Biomedical Research Learners for Long-Term Success
Voices
Aug 26, 2025, 15:59
Children's Cancer Institute Identifies Potential New Treatment Strategy for High-Risk Neuroblastoma
Insight
Aug 26, 2025, 15:57
Yüksel Ürün Highlights an Eexcellent Review of AI Across the Cancer Care Continuum
Voices
Aug 26, 2025, 15:54
Cathy Eng Celebrates SU2C Nashville and Support for Cancer Research Grants
Voices
Aug 26, 2025, 15:51
Bogda Koczwara on Addressing Discordance Between Cancer Patients' Preferences and Treatment Goals
Insight
Aug 26, 2025, 15:47
Catherine Alix-Panabières: From Discovery to Diagnosis - A Perspective for Circulating Tumor Cells in Personalized Oncology
Insight
Aug 26, 2025, 15:45
Haystack MRD by Quest Diagnostics Received FDA Breakthrough Device Designation
Voices
Aug 26, 2025, 15:36
Svetlana Nikic: Companies Don’t Even Know Where Their Access Barriers Actually Are
Insight
Aug 26, 2025, 15:28
Celia Diez de los Rios on the Importance of Clarity, Compassion, and Evidence in Cancer Care
Blog Posts
Aug 26, 2025, 15:24
Belén Garijo Reflects on 1,000 Days of AI: The Journey and What’s Next